Development of Ocular Rosacea following Combined Ipilimumab and Nivolumab Treatment for Metastatic Malignant Skin Melanoma
Author(s) -
Niels J. Brouwer,
John B.A.G. Haanen,
Martine J. Jager
Publication year - 2017
Publication title -
ocular oncology and pathology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.444
H-Index - 10
eISSN - 2296-4681
pISSN - 2296-4657
DOI - 10.1159/000455150
Subject(s) - medicine , ipilimumab , nivolumab , dermatology , rosacea , melanoma , metastatic melanoma , erythema , adverse effect , eyelid , immunotherapy , oncology , surgery , cancer , cancer research , acne
To report a case of severe ocular rosacea following ipilimumab plus nivolumab treatment in a patient with metastatic malignant skin melanoma.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom